Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction. This evidence concerns the gene SH3BP5 and metabolic dysfunction-associated steatohepatitis.